Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

844 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
Perz JB, Schonland SO, Hundemer M, Kristen AV, Dengler TJ, Zeier M, Linke RP, Ho AD, Goldschmidt H. Perz JB, et al. Among authors: goldschmidt h. Br J Haematol. 2004 Dec;127(5):543-51. doi: 10.1111/j.1365-2141.2004.05232.x. Br J Haematol. 2004. PMID: 15566357 Free article. Clinical Trial.
Risk stratification in cardiac amyloidosis: novel approaches.
Kristen AV, Meyer FJ, Perz JB, Schonland SO, Hundemer M, Hegenbart U, Singer R, Schnabel PA, Sack FU, Goldschmidt H, Katus HA, Dengler TJ. Kristen AV, et al. Among authors: goldschmidt h. Transplantation. 2005 Sep 27;80(1 Suppl):S151-5. doi: 10.1097/01.tp.0000187111.00076.1a. Transplantation. 2005. PMID: 16286895 Review.
Indications for liver transplantation in patients with amyloidosis: a single-center experience with 11 cases.
Singer R, Mehrabi A, Schemmer P, Kashfi A, Hegenbart U, Goldschmidt H, Schönland S, Kristen A, Dengler T, Müller-Schilling M, Sauer P, Dogan A, Hund E, Helmke B, Schnabel P, Altland K, Linke R, Friess H, Schmidt J, Büchler MW, Kraus TW. Singer R, et al. Among authors: goldschmidt h. Transplantation. 2005 Sep 27;80(1 Suppl):S156-9. doi: 10.1097/01.tp.0000186910.09213.bf. Transplantation. 2005. PMID: 16286896
Non-invasive predictors of survival in cardiac amyloidosis.
Kristen AV, Perz JB, Schonland SO, Hegenbart U, Schnabel PA, Kristen JH, Goldschmidt H, Katus HA, Dengler TJ. Kristen AV, et al. Among authors: goldschmidt h. Eur J Heart Fail. 2007 Jun-Jul;9(6-7):617-24. doi: 10.1016/j.ejheart.2007.01.012. Epub 2007 Mar 9. Eur J Heart Fail. 2007. PMID: 17350331 Free article.
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study.
Bourhis JH, Bouko Y, Koscielny S, Bakkus M, Greinix H, Derigs G, Salles G, Feremans W, Apperley J, Samson D, Björkstrand B, Niederwieser D, Gahrton G, Pico JL, Goldschmidt H; European Group for Blood and Marrow Transplantation. Bourhis JH, et al. Among authors: goldschmidt h. Haematologica. 2007 Aug;92(8):1083-90. doi: 10.3324/haematol.10535. Epub 2007 Jul 20. Haematologica. 2007. PMID: 17640853 Free article. Clinical Trial.
Treatment options for severe cardiac amyloidosis: heart transplantation combined with chemotherapy and stem cell transplantation for patients with AL-amyloidosis and heart and liver transplantation for patients with ATTR-amyloidosis.
Sack FU, Kristen A, Goldschmidt H, Schnabel PA, Dengler T, Koch A, Karck M. Sack FU, et al. Among authors: goldschmidt h. Eur J Cardiothorac Surg. 2008 Feb;33(2):257-62. doi: 10.1016/j.ejcts.2007.10.025. Epub 2007 Dec 21. Eur J Cardiothorac Surg. 2008. PMID: 18096396
844 results